Skip to main content
. 2025 May 15;16:245. doi: 10.1186/s13287-025-04371-w

Table 2.

Methods for the completed registered clinical trials using mesenchymal stem cells (MSCs) in sepsis. Each trial evaluated for cell derivation, number of donors, amount of doublings in culture, use of fresh versus cryopreserved cells, cell protocol details, and viability at time of injection

graphic file with name 13287_2025_4371_Tab2_HTML.jpg